首页> 中文期刊>药品评价 >慢性肾脏病住院患者降压药物的使用研究

慢性肾脏病住院患者降压药物的使用研究

     

摘要

目的:回顾性调查合并有高血压的住院慢性肾脏病患者降压药的使用,为临床合理用药提供依据。方法:调查2014年我院肾内科住院的合并有高血压的慢性肾脏病患者共196例进行统计分析。结果:67.35%患者使用联合降压方案,其中30.61%的患者两药联用,21.94%的患者三药联合。在降压药的选择上,使用频率最高的为RAS阻断剂(包括ACEI和ARB),占78.57%;其次为钙离子拮抗剂类降压药,占66.84%。结论:慢性肾脏病的高血压患者联合应用降压药的比例很高,临床应用时应密切随访,以避免不良反应的发生。%Objective: To investigate management and control of hypertension in hospitalized patients with chronic kidney disease and hypertension, and to provide reference for rational use of drugs.Methods: 196 patients with CKD and hypertension who hospitalized in our hospital urology department from 2014 were studied.Results: 67.35% patients were treated with a combined antihypertensive plan, in which, 30.61% patients used two kinds of drugs combination, and 21.94% patients used three kinds of drugs combination. Renin-angiotensin system(RAS) inhibitors(including ACEI and ARB) were the most frequently prescribed drug, taken by 78.57% patients, followed by CCB 66.84%.Conclusions: CKD accounts for a high proportion of combined use of antihypertensive drugs in hypertensive patients, thus the clinical application should be closely followed up, to avoid the occurrence of adverse reactions.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号